Schooner Investment Group’s Gilead Sciences GILD Stock Holding History

Schooner Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,000	Closed	-$390K	–	37
2016 Q3	$390K	Hold	5,000	–	–	1.54%	12
2016 Q2	$424K	Hold	5,000	–	–	1.03%	27
2016 Q1	$471K	Sell	5,000 -2,500	-33%	-$225K	0.9%	34
2015 Q4	$735K	Sell	7,500 -5,000	-40%	-$520K	1.38%	13
2015 Q3	$1.23M	Sell	12,500 -5,000	-29%	-$555K	0.88%	27
2015 Q2	$2.03M	Sell	17,500 -7,500	-30%	-$820K	0.95%	21
2015 Q1	$2.44M	Sell	25,000 -15,000	-38%	-$1.52M	0.88%	24
2014 Q4	$3.8M	Buy	+40,000	New	+$4.14M	1%	21

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schooner Investment Group's GILD Position: Q4 2016 in Review

Schooner Investment Group sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 5,000 shares — an estimated $390K sold.

Schooner Investment Group first reported a position in GILD in Q4 2014 and held it in 8 quarters. The position peaked at $3.8M in Q4 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Schooner Investment Group reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Schooner Investment Group sold 5,000 Gilead Sciences shares in Q4 2016, an estimated $390K.
Schooner Investment Group first reported a position in Gilead Sciences in Q4 2014 and held it in 8 quarters.
Schooner Investment Group's Gilead Sciences position peaked at $3.8M in Q4 2014.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Schooner Investment Group's 13F filing for Q4 2016, filed 13 Jan 2017.